| 摘要 |
The present invention provides a compound of formula (I): said compound is inhibitor of MMP-9, and/or MMP-12 and/or MMP-13, and thus can be employed for the treatment of a disorder or disease characterized by abnormal activity of MMP-9, and/or MMP-12 and/or MMP-13. Accordingly, the compound of formula (I) can be used in treatment of disorders or diseases mediated by MMP-9, and/or MMP-12 and/or MMP-13. Finally, the present invention also provides a pharmaceutical composition. |
| 申请人 |
NOVARTIS AG;NOVARTIS PHARMA GMBH;PUSATERI, ERIN, E.;TOMMASI, RUBEN, ALBERTO;LEUTERT, THOMAS;GROB, JONATHAN, E.;HONDA, AYAKO |
发明人 |
PUSATERI, ERIN, E.;TOMMASI, RUBEN, ALBERTO;LEUTERT, THOMAS;GROB, JONATHAN, E.;HONDA, AYAKO |
